Methods for joint lubrication and cartilage wear prevention making use of glycerophospholipids
The present invention concerns methods of joint lubrication and/or prevention of cartilage wear making use of liposomes having membranes with at least one phospholipid (PL) of the group consisting of a glycerophospholipid (GPL) having two, being the same or different, C 12 -C 16 hydrocarbon chain and a sphingolipid (SPL) having a C 12 -C 15 hydrocarbon chain, the one or more membranes having a phase transition temperature in which solid ordered (SO) to liquid disordered (LD) phase transition occurs, the phase transition temperature being within a temperature of about 20° C. to about 39° C. for lubrication of joints.
1. A method for lubricating a joint of a mammal, the method comprising: administering into a cavity of the joint having a first temperature a composition consisting essentially of liposomes, wherein said liposomes are multilamellar vesicles (MLV) dispersed in a fluid medium, the liposomes having a mean diameter of between about 0.8 μm to about 10 μm and consisting essentially of membranes including at least one phospholipid (PL) selected from the group consisting of dimyristoylphosphatidylcholine (DMPC) and a mixture of DMPC and dipalmitoyl-phosphatidylcholine (DPPC), the membranes having a phase transition temperature in which solid ordered (SO) to liquid disordered (LD) phase transition occurs, the phase transition temperature being at a temperature of about 20° C. to about 39° C.; the phase transition temperature being lower than the first temperature.
2. The method of claim 1 , wherein said PL is dimyristoylphosphatidylcholine (DMPC).
3. The method of claim 1 , wherein said PL is the mixture of DMPC and DPPC.
4. The method of claim 3 , wherein the ratio of DMPC to DPPC is at least 0.6/1.0 (mole/mole).
5. The method claim 1 , wherein said liposomes do not include a membrane active sterol.
6. The method of claim 1 , for the treatment of or prevention of an articular disorder or symptoms arising therefrom or for the treatment, management or prevention of deterioration of locked joints, sports injury or traumatic injury towards osteoarthritis (OA).
7. The method of claim 6 , wherein said articular disorder is selected from arthritis, osteoarthritis, osteoarthritis in rheumatoid arthritis patients, traumatic joint injury, locked joint, sports injury, status post arthrocentesis, arthroscopic surgery, open joint surgery, and joint replacement.
8. A method for reducing or preventing a mammal's cartilage wear, the method comprising: administering into a cavity of a mammal's joint having a first temperature a composition consisting essentially of liposomes, wherein said liposomes are multilamellar vesicles (MLV) dispersed in a fluid medium, the liposomes having a mean diameter of between about 0.8 μm to about 10 μm and consisting essentially of membranes including at least one phospholipid (PL) selected from the group consisting of dimyristoylphosphatidylcholine (DMPC) and a mixture of DMPC and dipalmitoyl-phosphatidylcholine (DPPC), the membranes having a phase transition temperature in which solid ordered (SO) to liquid disordered (LD) phase transition occurs, the phase transition temperature being at a temperature of about 20° C. to about 39° C.; the phase transition temperature being lower than the first temperature.
9. The method of claim 8 , wherein said PL is dimyristoylphosphatidylcholine (DMPC).
10. The method of claim 8 , wherein said PL is the mixture of DMPC and DPPC.
11. The method of claim 10 , wherein the ratio of DMPC to DPPC is at least 0.6/1.0 (mole/mole).
12. The method claim 8 , wherein said liposomes do not include a membrane active sterol.
13. The method of claim 8 , for the treatment of or prevention of an articular disorder or symptoms arising therefrom or for the treatment, management or prevention of deterioration of locked joints, sports injury or traumatic injury towards osteoarthritis (OA).
14. The method of claim 13 , wherein said articular disorder is selected from arthritis, osteoarthritis, osteoarthritis in rheumatoid arthritis patients, traumatic joint injury, locked joint, sports injury, status post arthrocentesis, arthroscopic surgery, open joint surgery, and joint replacement.
15. The method of claim 1 , wherein the liposomes do not include dextran.
16. The method of claim 8 , wherein the liposomes do not include dextran.
17. A method for lubricating a joint of a mammal for reducing or preventing cartilage wear, the method comprising:
selecting phospholipids that form liposomes having a phase transition temperature that is in the range of about 20° C. to about 39° C.;
forming a composition consisting essentially of liposomes of multilamellar vesicles (MLV) dispersed in a fluid medium and having a mean diameter of between about 0.8 μm to about 10 μm, wherein the liposomes are formed from phospholipid (PL) membranes consisting essentially of dimyristoylphosphatidylcholine (DMPC) or a mixture of DMPC and another PL, provided that in the mixture the DMPC and other PL are present in a ratio of at least 0.6/1.0 (mole/mole) and that the membranes have a phase transition temperature in which solid ordered (SO) to liquid disordered (LD) phase transition occurs in the in the selected range of about 20° C. to about 39° C.; and
administering the selected compositions into a cavity of the joint, wherein the joint has a first temperature and the phase transition temperature of the selected composition is lower than the first temperature.